Prosecution Insights
Last updated: October 26, 2026

Jonghwan Nmn Baek, USPTO Patent Examiner

Listed by the USPTO as BAEK, JONGHWAN NMN

Tech Center 3700 • Art Units: 1618 1759 3791

This examiner grants 50% of resolved cases

Analysis

BAEK, JONGHWAN NMN is a USPTO patent examiner in tech center 3700 and art unit 1618. The profile contains 6 resolved cases, an allowance rate of 50.0%, and a median of 1032 days to allowance. The interview lift is 0.0%.

The listed companies are Purdue Research Foundation, The University of British Columbia, and Riken. The leading firms are GOODWIN PROCTER LLP, Casimir Jones, S.C., and Kilpatrick Townsend & Stockton LLP - West Coast. The small recorded case set limits broad inferences, so practitioners should treat the figures as an early reference and rely on application-specific analysis when preparing claims, responses, and examiner interviews.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

50.0%
Allow Rate
-20.0% vs TC avg
61
Total Applications
+0.0%
Interview Lift
1032
Avg Prosecution Days
Based on 6 resolved cases, 2023–2026

Rejection Statute Breakdown

3.1%
§101 Eligibility
10.2%
§102 Novelty
41.3%
§103 Obviousness
26.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18196229 IMAGING PHANTOM Final Rejection The Regents of the University of Michigan
18700598 FLUORINE-CONTAINING COMPOUND AND CONTRAST AGENT Non-Final OA TDK CORPORATION
18066441 FORMATION AND USE OF EMBEDDED SOLUTIONS IN NANOSCALE MATERIALS Final Rejection The Regents of the University of California
18434796 PRECISION RADIOPHARMACEUTICAL THERAPY OF LYMPHOMA AND OTHER DISEASES Non-Final OA WASHINGTON UNIVERSITY
17860684 METHOD FOR CREATING A RENAL INJURY MODEL TO SCREEN MOLECULES FOR THE TREATMENT OF RENAL INJURY Non-Final OA Bayer Aktiengesellschaft
18826309 ANTIMONY CHELATES FOR TARGETED AUGER THERAPY AND IMAGING DIAGNOSTICS Non-Final OA UT-Battelle, LLC
18571271 VINYLATED KETO ESTERS WITH APPLICABILITY IN SIGNAL ENHANCED MAGNETIC RESONANCE IMAGING AND SYNTHESIS THEREOF Non-Final OA MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E. V.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Jonghwan Nmn Baek's allowance rate?

50.0% of resolved applications examined by Jonghwan Nmn Baek were allowed (6 resolved cases), compared with 33.1% across Art Unit 1618 over the last five years.

Does an interview help with examiner Jonghwan Nmn Baek?

This examiner's interview lift is +0.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Jonghwan Nmn Baek take to allow a patent?

Applications allowed by Jonghwan Nmn Baek took 1,032 days on average from filing to allowance.

Which art unit does examiner Jonghwan Nmn Baek work in?

Jonghwan Nmn Baek examines applications in Art Unit 1618 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month